Therapeutic potential of using the vascular disrupting agent OXi4503 to enhance mild temperature thermoradiation

Induction of hypoxia by vascular disrupting agents and the significance for their combination with radiation therapy

(2013) Ane B. Iversen et al.   ACTA ONCOLOGICA

Effects of bevacizumab and hyperthermia in a rodent model of hyperthermic intraperitoneal chemotherapy (HIPEC)

(2013) Johanna Verhulst   INTERNATIONAL JOURNAL OF HYPERTHERMIA

Combination of vascular disrupting agents and ionizing radiation

(2012) Céline Clémenson et al.   CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY

Blood flow and associated pathophysiology of uterine cervix cancers: Characterisation and relevance for localised hyperthermia

(2012) Peter W. Vaupel et al.   INTERNATIONAL JOURNAL OF HYPERTHERMIA

Usefulness of combined treatment with continuous administration of tirapazamine and mild temperature hyperthermia inγ-ray irradiation in terms of local tumour response and lung metastatic potential

(2012) Shin-Ichiro Masunaga et al.   INTERNATIONAL JOURNAL OF HYPERTHERMIA

Hyperthermia worsens ischaemic brain injury through destruction of microvessels in an embolic model in rats

(2012) Qiang Meng et al.   INTERNATIONAL JOURNAL OF HYPERTHERMIA

Review of radiotherapy and hyperthermia in primary cervical cancer

(2012) Martine Franckena   INTERNATIONAL JOURNAL OF HYPERTHERMIA

Vascular Disrupting Agent Arsenic Trioxide Enhances Thermoradiotherapy of Solid Tumors

(2012) Robert J. Griffin et al.   Journal of Oncology

Vascular targeted therapies in oncology

(2008) Dietmar W. Siemann et al.   CELL AND TISSUE RESEARCH